Aprezo 30 mg Glenmark Pharmaceuticals Ltd.

Code: EU14134
€36.00
Esaurito
Certified products
Certified products
We only sell certified products from the world's most famous brands!
Convenient payment
Convenient payment
You can transfer funds to a bank account or a USDT crypto wallet.
Fast delivery
Fast delivery
We will deliver your order within a few days.
Description Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
Specification Aprezo 30 mg Glenmark Pharmaceuticals Ltd.
Features
Active substance
Apremilast
Also known as
CC-10004
Blood pressure
No significant effects on blood pressure
Chemical name
N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide
Dosage (medical)
30 mg twice daily after initial titration
Dosage (sports)
Not applicable
Effects
Reduces inflammation by inhibiting PDE4, an enzyme involved in the process of inflammatory response
Formula
C22H24N2O7S
Half-life
Approximately 6-9 hours
Hepatotoxicity
Minimal to no hepatotoxicity reported
Lab Test
Monitoring is not typically required for liver enzymes unless under specific medical advice
Main action
Anti-inflammatory
Side effects
Diarrhea, nausea, headache, upper respiratory tract infection, weight loss
Storage conditions
Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F)
Strength
30mg
Substance class
Phosphodiesterase 4 (PDE4) inhibitor
Trade name
Otezla
Use in sports
Not typically used in sports, lacks performance-enhancing properties
Water Retention
No significant effect
Manufacturer
Glenmark Pharmaceuticals Ltd.
Packing
10 tabs/blister
Reviews
Average rating
0
Reviews (0)
5
0
4
0
3
0
2
0
1
0